Enanta Pharmaceuticals Inc (ENTA)
12.49
+0.49
(+4.08%)
USD |
NASDAQ |
May 31, 16:00
12.43
-0.06
(-0.48%)
After-Hours: 20:00
Enanta Pharmaceuticals Revenue (Annual): 79.20M for Sept. 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 79.20M |
| September 30, 2022 | 86.16M |
| September 30, 2021 | 97.07M |
| September 30, 2020 | 122.47M |
| September 30, 2019 | 205.20M |
| September 30, 2018 | 206.62M |
| September 30, 2017 | 102.81M |
| Date | Value |
|---|---|
| September 30, 2016 | 88.27M |
| September 30, 2015 | 160.88M |
| September 30, 2014 | 47.74M |
| September 30, 2013 | 32.05M |
| September 30, 2012 | 41.71M |
| September 30, 2011 | 41.88M |
| September 30, 2010 | 22.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
79.20M
Minimum
2023
205.20M
Maximum
2019
118.02M
Average
97.07M
Median
2021